Michael John Gill

Employment

• University of Calgary Professor
  1984 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (307)

• Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV
  Clinical Infectious Diseases 2026 DOI: 10.1093/cid/ciaf635
  +Save
• Evaluation of A Phylogenetic Pipeline to Examine Transmission Networks in A Canadian HIV Cohort
  Microorganisms 2020 DOI: 10.3390/microorganisms8020196
  +Save
• Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration
  Journal of Clinical Medicine 2018 DOI: 10.3390/jcm7100328
  +Save
• Heterophilic interface in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
  J Clin Virol 2018
  +Save
• Collaboration. Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions.
  JAIDS 2018
  +Save
• Patient perspectives on de-simplifying their single tablet co formulated (STF) antiretroviral therapy for societal cost savings.
  HIV Medicine 2018 DOI: doi: 10.1111/hiv.12578
  +Save
• Week 96 results of the randomized, multicenter Maraviroc Switch (MARCH) study.
  HIV Med 2018
  +Save
• A Flow-Based Model of the HIV Care Continuum in the United States
  Jaids-Journal of Acquired Immune Deficiency Syndromes 2017 DOI: 10.1097/QAI.0000000000001429
  +Save
• A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection
  Plos One 2017 DOI: 10.1371/journal.pone.0176282
  +Save
• Associations between depressive Symptomatology and Neurocognitive impairment in HIV-AIDS.
  Can J Psychiatry . 2017 DOI: doi: 10.1177/0706743717737029
  +Save